{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:59:00Z","timestamp":1793980740978,"version":"4.8.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jns.2021.117481","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T21:09:37Z","timestamp":1620076177000},"page":"117481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["White matter hyperintensities in patients with Parkinson's disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"426","author":[{"given":"Asif","family":"Butt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kamtchum-Tatuene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurshid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashfaq","family":"Shuaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen C.","family":"Jickling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis M.","family":"Miyasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Camicioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jns.2021.117481_bb0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40478-015-0222-2","article-title":"Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by \u03b1-synuclein overexpression","volume":"3","author":"Bourdenx","year":"2015","journal-title":"Acta Neuropathologica Communicat."},{"issue":"7","key":"10.1016\/j.jns.2021.117481_bb0010","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.neuropharm.2012.01.028","article-title":"Contributions of central and systemic inflammation to the pathophysiology of Parkinson\u2019s disease","volume":"62","author":"Collins","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jns.2021.117481_bb0015","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399411001918","article-title":"Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases","volume":"13","author":"Grammas","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"issue":"5","key":"10.1016\/j.jns.2021.117481_bb0020","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.bbadis.2015.12.016","article-title":"Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer\u2019s disease","volume":"1862","author":"Nelson","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.jns.2021.117481_bb0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.jns.2021.117481_bb0030","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s11357-012-9470-2","article-title":"Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockage","volume":"35","author":"Rodriguez-Perez","year":"2013","journal-title":"Age (Dordr.)"},{"key":"10.1016\/j.jns.2021.117481_bb0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.parkreldis.2020.04.004","article-title":"Ischemic injury precipitates neuronal vulnerability in Parkinson\u2019s disease: insights from PINK1 mouse model study and clinical retrospective data","volume":"74","author":"Imbriani","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"issue":"10","key":"10.1016\/j.jns.2021.117481_bb0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrneurol.2009.136","article-title":"Parkinson disease and comorbid cerebrovascular disease","volume":"5","author":"Nanhoe-Mahabier","year":"2009","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2021.117481_bb0045","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.clineuro.2011.05.014","article-title":"Prevalence of radiological and clinical cerebrovascular disease in idiopathic Parkinson\u2019s disease","volume":"113","author":"Patel","year":"2011","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"6","key":"10.1016\/j.jns.2021.117481_bb0050","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001140","article-title":"What are white matter hyperintensities made of? Relevance to vascular cognitive impairment","volume":"4","author":"Wardlaw","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.jns.2021.117481_bb0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archneur.1995.00540260097023","article-title":"White matter hyperintensities in Parkinson\u2019s disease. Clinical correlations","volume":"52","author":"Piccini","year":"1995","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.117481_bb0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000117098","article-title":"Evaluation of influential factors of cognitive impairments in idiopathic Parkinson\u2019s disease","volume":"35","author":"Fukui","year":"1995","journal-title":"Eur. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.117481_bb0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/mds.20704","article-title":"Visual rating of white matter hyperintensities in Parkinson\u2019s disease","volume":"21","author":"Beyer","year":"2006","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.jns.2021.117481_bb0070","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/01.JGP.0000236596.56982.1c","article-title":"Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging","volume":"14","author":"Burton","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"7","key":"10.1016\/j.jns.2021.117481_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"9","key":"10.1016\/j.jns.2021.117481_bb0080","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jns.2021.117481_bb0085","series-title":"Dissemination, and Implementation Subcommittee of the and e.a. American Academy of Neurology, Clinical Practice Guideline Process Manual, 2017 ed","first-page":"2017","author":"Gronseth","year":"2017"},{"key":"10.1016\/j.jns.2021.117481_bb0090","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1177\/0962280219889080","article-title":"Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis","volume":"29(9)","author":"McGrath","year":"2020","journal-title":"Stat. Methods Med. Res."},{"issue":"4","key":"10.1016\/j.jns.2021.117481_bb0095","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7150\/ijms.18025","article-title":"Parkinson\u2019s disease might increase the risk of cerebral ischemic lesions","volume":"14","author":"Song","year":"2017","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.jns.2021.117481_bb0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1017\/S0317167100005795","article-title":"Axial signs and magnetic resonance imaging correlates in Parkinson's disease","volume":"34","author":"Acharya","year":"2007","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.jns.2021.117481_bb0105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fnagi.2017.00213","article-title":"White matter changes-related gait and executive function deficits: associations with age and Parkinson\u2019s disease","volume":"9","author":"Sartor","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jns.2021.117481_bb0110","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.nicl.2018.09.025","article-title":"White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients","volume":"20","author":"Dadar","year":"2018","journal-title":"Neuroimage Clin"},{"issue":"3","key":"10.1016\/j.jns.2021.117481_bb0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jnnp-2011-300872","article-title":"Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson\u2019s disease patients according to cognitive status","volume":"83","author":"Shin","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2021.117481_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2016.03.031","article-title":"Age-dependent cognitive and affective differences in Alzheimer\u2019s and Parkinson\u2019s diseases in relation to MRI findings","volume":"365","author":"Tokuchi","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.jns.2021.117481_bb0125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jns.2012.07.021","article-title":"White matter lesions and depression in patients with Parkinson\u2019s disease","volume":"322","author":"Petrovic","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2021.117481_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nicl.2014.07.014","article-title":"Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease","volume":"6","author":"Al-Bachari","year":"2014","journal-title":"NeuroImage Clin."},{"issue":"8","key":"10.1016\/j.jns.2021.117481_bb0135","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1007\/s00415-014-7403-y","article-title":"Cerebral microbleeds in patients with Parkinson\u2019s disease","volume":"261","author":"Ham","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.117481_bb0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.parkreldis.2015.12.017","article-title":"Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson\u2019s disease","volume":"24","author":"Ham","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2021.117481_bb0145","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jns.2016.06.009","article-title":"White matter hyperintensities, cerebrospinal amyloid-beta and dementia in Parkinson\u2019s disease","volume":"367","author":"Compta","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.jns.2021.117481_bb0150","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s11682-018-9909-x","article-title":"Episodic memory decline in Parkinson' s disease: relation with white matter hyperintense lesions and influence of quantification method","volume":"13","author":"Dunet","year":"2019","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.jns.2021.117481_bb0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2017.12.018","article-title":"White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson\u2019s disease with dementia, and Alzheimer\u2019s disease","volume":"385","author":"Joki","year":"2018","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2021.117481_bb0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"Am. J. Roentgenol."},{"issue":"1","key":"10.1016\/j.jns.2021.117481_bb0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0022-510X(93)90041-V","article-title":"A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging","volume":"114","author":"Scheltens","year":"1993","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.jns.2021.117481_bb0170","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","article-title":"A new rating scale for age-related white matter changes applicable to MRI and CT","volume":"32","author":"Wahlund","year":"2001","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.jns.2021.117481_bb0175","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1161\/01.STR.0000183615.07936.b6","article-title":"A new visual rating scale to assess strategic white matter Hyperintensities within cholinergic pathways in dementia","volume":"36","author":"Bocti","year":"2005","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.jns.2021.117481_bb0180","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1177\/0271678X16688919","article-title":"Structural and physiological neurovascular changes in idiopathic Parkinson\u2019s disease and its clinical phenotypes","volume":"37","author":"Al-Bachari","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"4","key":"10.1016\/j.jns.2021.117481_bb0185","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1017\/S1355617717000017","article-title":"Are Parkinson\u2019s patients more vulnerable to the effects of cardiovascular risk: a neuroimaging and neuropsychological study","volume":"23","author":"Jones","year":"2017","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"15","key":"10.1016\/j.jns.2021.117481_bb0190","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/mds.22754","article-title":"Brain atrophy and white matter hyperintensities in early Parkinson\u2019s disease","volume":"24","author":"Dalaker","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.117481_bb0195","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clineuro.2018.02.013","article-title":"Extracranial arterial wall volume is increased and shows relationships with vascular MRI measures in idiopathic Parkinson's disease","volume":"167","author":"Ball","year":"2018","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"2","key":"10.1016\/j.jns.2021.117481_bb0200","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/ene.13797","article-title":"Modifiable vascular risk factors, white matter disease and cognition in early Parkinson\u2019s disease","volume":"26","author":"Chahine","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2021.117481_bb0205","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neurobiolaging.2019.05.004","article-title":"Age- and disease-related cerebral white matter changes in patients with Parkinson\u2019s disease","volume":"80","author":"de Schipper","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2021.117481_bb0210","doi-asserted-by":"crossref","first-page":"101870","DOI":"10.1016\/j.nicl.2019.101870","article-title":"Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease","volume":"23","author":"Pozorski","year":"2019","journal-title":"Neuroimage Clin"},{"issue":"4","key":"10.1016\/j.jns.2021.117481_bb0215","first-page":"875","article-title":"Measuring longitudinal white matter changes: comparison of a visual rating scale with a volumetric measurement","volume":"27","author":"van den Heuvel","year":"2006","journal-title":"Am. J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.jns.2021.117481_bb0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/jnnp.70.1.9","article-title":"Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study","volume":"70","author":"de Leeuw","year":"2001","journal-title":"J. Neurol. Neurosur. Psychiat."},{"issue":"1","key":"10.1016\/j.jns.2021.117481_bb0225","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1148\/radiol.2371041496","article-title":"Brain white matter Hyperintensities: relative importance of vascular risk factors in nondemented elderly people","volume":"237","author":"Murray","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.jns.2021.117481_bb0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fnagi.2013.00017","article-title":"Pathology and pathogenesis of vascular cognitive impairment-a critical update","volume":"5","author":"Jellinger","year":"2013","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2021.117481_bb0235","article-title":"The temporal relationships between white matter hyperintensities, neurodegeneration, amyloid beta, and cognition","volume":"12","author":"Dadar","year":"2020","journal-title":"Alzheimer's & dementia (Amsterdam, Netherlands)"},{"issue":"3","key":"10.1016\/j.jns.2021.117481_bb0240","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3233\/JPD-181351","article-title":"Brain-area specific white matter Hyperintensities: associations to falls in Parkinson\u2019s disease","volume":"8","author":"Ciliz","year":"2018","journal-title":"J. Parkinsons Dis."},{"issue":"2","key":"10.1016\/j.jns.2021.117481_bb0245","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1533317512470207","article-title":"Diffusion tensor imaging reveals white matter changes associated with cognitive status in patients with Parkinson\u2019s disease","volume":"28","author":"Deng","year":"2013","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"issue":"7","key":"10.1016\/j.jns.2021.117481_bb0250","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s00415-018-8873-0","article-title":"Longitudinal diffusion tensor imaging changes in early Parkinson\u2019s disease: ICICLE-PD study","volume":"265","author":"Minett","year":"2018","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2021.117481_bb0255","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/STROKEAHA.112.680223","article-title":"Changes in normal-appearing white matter precede development of white matter lesions","volume":"44","author":"de Groot","year":"2013","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jns.2021.117481_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175143","article-title":"Effectiveness of diffusion tensor imaging in differentiating early-stage subcortical ischemic vascular disease, Alzheimer's disease and normal ageing","volume":"12","author":"Tu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2021.117481_bb0265","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nicl.2017.07.011","article-title":"Diffusion tensor imaging in Parkinson\u2019s disease: review and meta-analysis","volume":"16","author":"Atkinson-Clement","year":"2017","journal-title":"Neuroimage Clin"},{"issue":"1","key":"10.1016\/j.jns.2021.117481_bb0270","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s42466-020-00092-y","article-title":"A machine learning-based classification approach on Parkinson\u2019s disease diffusion tensor imaging datasets","volume":"2","author":"Prasuhn","year":"2020","journal-title":"Neurol. Res. Pract."},{"issue":"1","key":"10.1016\/j.jns.2021.117481_bb0275","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/bpa.12769","article-title":"Small vessel disease pathological changes in neurodegenerative and vascular dementias concomitant with autonomic dysfunction","volume":"30","author":"Hase","year":"2020","journal-title":"Brain Pathol."},{"issue":"1\u20133","key":"10.1016\/j.jns.2021.117481_bb0280","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000285518","article-title":"Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases","volume":"7","author":"Jellinger","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.jns.2021.117481_bb0285","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jocn.2018.10.029","article-title":"Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson\u2019s disease","volume":"58","author":"Schwartz","year":"2018","journal-title":"J. Clin. Neurosci."},{"issue":"12","key":"10.1016\/j.jns.2021.117481_bb0290","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/mds.25112","article-title":"Small-vessel disease in patients with Parkinson\u2019s disease: a clinicopathological study","volume":"27","author":"Schwartz","year":"2012","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.jns.2021.117481_bb0295","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/NEN.0b013e3181d88e63","article-title":"Inverse relationship between cerebrovascular lesions and severity of lewy body pathology in patients with lewy body diseases","volume":"69","author":"Ghebremedhin","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2021.117481_bb0300","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neurobiolaging.2020.08.005","article-title":"White matter hyperintensities and the progression from mild parkinsonian signs to parkinsonism and Parkinson\u2019s disease","volume":"96","author":"Huo","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.jns.2021.117481_bb0305","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3349\/ymj.1998.39.1.50","article-title":"The influence of white matter hyperintensities on the clinical features of Parkinson\u2019s disease","volume":"39","author":"Sohn","year":"1998","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.jns.2021.117481_bb0310","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.parkreldis.2016.01.017","article-title":"Influence of white matter MRI hyper-intensities on acute l-dopa response in patients with Parkinson\u2019s disease","volume":"24","author":"Arena","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Pt 8","key":"10.1016\/j.jns.2021.117481_bb0315","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1093\/brain\/awr139","article-title":"Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson\u2019s disease","volume":"134","author":"Bohnen","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jns.2021.117481_bb0320","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jns.2016.06.015","article-title":"White matter changes and the development of motor phenotypes in de novo Parkinson\u2019s disease","volume":"367","author":"Moccia","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jns.2021.117481_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055193","article-title":"White matter hyperintensities in Parkinson's disease: do they explain the disparity between the postural instability gait difficulty and tremor dominant subtypes?","volume":"8","author":"Herman","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2021.117481_bb0330","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.parkreldis.2021.02.031","article-title":"White matter hyperintensities mediate the impact of amyloid \u00df on future freezing of gait in Parkinson\u2019s disease","volume":"85","author":"Dadar","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.jns.2021.117481_bb0335","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.archger.2008.09.005","article-title":"The severity of leukoaraiosis correlates with the clinical phenotype of Parkinson\u2019s disease","volume":"49","author":"Lee","year":"2009","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"4","key":"10.1016\/j.jns.2021.117481_bb0340","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1219","article-title":"Exploring the association between cerebral small-vessel diseases and motor symptoms in Parkinson\u2019s disease","volume":"9","author":"Wan","year":"2019","journal-title":"Brain Behav"},{"issue":"2\u20133","key":"10.1016\/j.jns.2021.117481_bb0345","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000489311","article-title":"Association between white matter lesions and non-motor symptoms in Parkinson disease","volume":"18","author":"Lee","year":"2018","journal-title":"Neurodegener. Dis."},{"issue":"6","key":"10.1016\/j.jns.2021.117481_bb0350","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/ene.12412","article-title":"The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson\u2019s disease","volume":"21","author":"Sunwoo","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2021.117481_bb0355","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.archger.2015.10.006","article-title":"The cross-sectional and longitudinal relationships between white matter hyperintensities and dementia in patients with Parkinson\u2019s disease: a retrospective analysis of 132 patients in a single center","volume":"62","author":"Lee","year":"2016","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"11","key":"10.1016\/j.jns.2021.117481_bb0360","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.parkreldis.2014.08.024","article-title":"Hippocampal volume and white matter disease in the prediction of dementia in Parkinson\u2019s disease","volume":"20","author":"Kandiah","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2021.117481_bb0365","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.dadm.2019.01.002","article-title":"Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration","volume":"11","author":"Smith","year":"2019","journal-title":"Alzheimer's & dementia (Amsterdam, Netherlands)"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21001751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21001751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:54:37Z","timestamp":1758383677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21001751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":73,"alternative-id":["S0022510X21001751"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.117481","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"White matter hyperintensities in patients with Parkinson's disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.117481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117481"}}